GPLD1 and neoplasm: This work and an earlier study [31] demonstrates that PLD inhibitors decrease breast cancer tumor growth and reduce the appearance of TAMs and TANs infiltrated in the tumor microenvironment, indicating a potential therapeutic value for these molecules.